Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 4, December

Natural Products and Derivatives as Leads to Cell Cycle Pathway Targets in Cancer Chemotherapy

Volume:2   Issue: 4
Pp: 279-308
David J. Newman, Gordon M. Cragg, Susan Holbeck and Edward A. Sausville
DOI: 10.2174/1568009023333791
Published on: 01 March, 2012

Modulating Cell Cycle: Current Applications and Prospects for Future Drug Development

Volume:2   Issue: 4
Pp: 309-336
Hala Gali-Muhtasib and Nadine Bakkar
DOI: 10.2174/1568009023333809
Published on: 01 March, 2012

Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress

Volume:2   Issue: 4
Pp: 337-353
B. G. Gabrielli, R. W. Johnstone and N. A. Saunders
DOI: 10.2174/1568009023333818
Published on: 01 March, 2012

The Use of Synthetic Oligonucleotides as Protein Inhibitors and Anticode Drugs in Cancer Therapy: Accomplishments and Limitations

Volume:2   Issue: 4
Pp: 355-368
Marcella Faria and Henning Ulrich
DOI: 10.2174/1568009023333827
Published on: 01 March, 2012